Back to search

Tumor-infiltrating dendritic cells are defective in their antigen-presenting function and inducible B7 expression in rats

Data up to Jan 2025

Published1997
Citations186
References25

Total Citations Per Year

Abstract

References (25)

Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.

1994 • 5,204 citations

The Dendritic Cell System and its Role in Immunogenicity

1991 • 4,733 citations

Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells

1996 • 1,908 citations

CTLA-4 is a second receptor for the B cell activation antigen B7.

1991 • 1,662 citations

CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones

1992 • 1,573 citations

Activation of human dendritic cells through CD40 cross-linking.

1994 • 1,351 citations

Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy

1992 • 1,290 citations

Tumor Antigens Recognized by T Lymphocytes

1994 • 1,238 citations

The tissue distribution of the B7-2 costimulator in mice: abundant expression on dendritic cells in situ and during maturation in vitro.

1994 • 607 citations

Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation.

1993 • 569 citations

Regulation of immunostimulatory function and costimulatory molecule (B7-1 and B7-2) expression on murine dendritic cells.

1994 • 379 citations

CD28 costimulation inhibits TCR-induced apoptosis during a primary T cell response.

1996 • 198 citations

B7-1 expression of Langerhans cells is up-regulated by proinflammatory cytokines, and is down-regulated by interferon-γ or by interleukin-10

1995 • 175 citations

Human sunlight-induced basal-cell-carcinoma-associated dendritic cells are deficient in T cell co-stimulatory molecules and are impaired as antigen-presenting cells.

1997 • 170 citations

The Role of B7-1/B7-2:CD28/CLTA-4 Pathways in the Prevention of Anergy, Induction of Productive Immunity and Down-Regulation of the Immune Response

1996 • 161 citations

Inflammatory cells infiltrating human colorectal carcinomas express HLA class II but not B7-1 and B7-2 costimulatory molecules of the T-cell activation.

1996 • 160 citations

Does B7-1 expression confer antigen-presenting cell capacity to tumors in vivo?

1996 • 147 citations

Dendritic cells and tolerance induction

1996 • 128 citations

Interaction between two cellular subpopulations of a rat colonic carcinoma when inoculated to the syngeneic host

1985 • 119 citations

In situ expression of B7 and CD28 receptor families in human malignant melanoma: Relevance for T‐cell‐mediated anti‐tumor immunity

1995 • 57 citations

Tumor-rejection antigens recognized by T lymphocytes

1993 • 45 citations

Surface phenotype and functions of tumor‐infiltrating dendritic cells: CD8 expression by a cell subpopulation

1993 • 42 citations

Specificity of the immune response leading to protection or enhancement by regressive and progressive variants of a rat colon carcinoma

1988 • 38 citations

The primary alloresponse of human CD4+ T cells is dependent on B7 (CD80), augmented by CD58, but relatively uninfluenced by CD54 expression

1995 • 33 citations

T-cell co-stimulation by the CD28 ligand B7 is involved in the immune response leading to rejection of a spontaneously regressive tumor

1996 • 15 citations

Cited By (0)

No citing papers found in database

Tumor-infiltrating dendritic cells are defective in their antigen-presenting function and… (1997) – International Journal of Cancer | Metascience Observatory Explorer